Emilio Bria

43PUBLICATIONS

181CO-AUTHORS

Liquid biopsiesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (43)

Sort by Publication Date:

|Jun 12, 2026

Liquid Biopsy Monitoring in <i>BRAF</i> V600E-Mutated Patients With Non-Small Cell Lung Cancer Treated With Dabrafenib Plus Trametinib: The Prospective, Multicenter LiBRA Study (GOIRC-03-2020).

|May 30, 2026

Amivantamab in advanced non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations: Real-world data from the Italian ATLAS Registry.

|Apr 03, 2026

Sequential Use of Trastuzumab Deruxtecan and Sacituzumab Govitecan in Patients with Breast Cancer: A Pharmacological Approach to Support the Clinical Rationale.

Marzia Del Re, Elvira Inglese, Emilio Bria

|Nov 12, 2025

PI3K/mTORC2-RICTOR axis in early squamous non-small-cell lung cancer: genomics, molecular expression, and clinical relevance.

Sara Pilotto, Lorenzo Belluomini, Federico Monaca

|Sep 29, 2025

Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry.

Alessio Cortellini, Valentina Santo, Leonardo Brunetti

|Aug 08, 2025

Unlocking the Immune Response in ALK-Rearranged Lung Adenocarcinoma.

Antonio Vitale, Emilio Bria

Pageof 8

Frequent Collaborators

Emanuele Vita

Lorenzo Belluomini

Aldo Scarpa

Sara Pilotto

Antonio Vitale

Chiara Bazzichetto

Marco Cintoni

Carmelo Pozzo

Maria Cristina Mele

Emanuele Rinninella

Frequent Collaborators

Emanuele Vita

Lorenzo Belluomini

Aldo Scarpa

Sara Pilotto